RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- MAZOR ROBOTICS
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- POALIM
- SHUFERSAL
- SODASTREAM
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
Accenture PLC Cisco Systems Inc 21st Century Fox Inc	Target Corp. General Electric Wal Mart Stores	Target Corp. Wal Mart Stores Home Depot, Inc
More documents (996)	More documents (869)	More documents (1714)
REGISTRATION DOCUMENT	20F	AGM
General Electric Time Warner Inc	Hewlett-Packard Co.	Philip Morris International Philip Morris International Philip Morris International
More documents (2)	More documents (1)	More documents (22)
INTERNAL CONTROL	ANNUAL INFO MEMO ART
Colgate-Palmolive	Target Corp.
More documents (1)	More documents (1)

PERMANENT INFORMATION

2019.01.15 | 08:00 | Permanent Information Releases / Notification of availability

GENERAL ELECTRIC

Doc re: GE files Form 8-K - HTML (w)

2019.01.04 | 13:30 | Permanent Information Releases / General Company News

BIOGEN IDEC INC

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets - HTML (w)

2019.01.04 | 13:30 | Permanent Information Releases / General Company News

BIOGEN IDEC INC

Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions - HTML (w)

2019.01.03 | 13:30 | Permanent Information Releases / General Company News

BIOGEN IDEC INC

First Patient Enrolled in Biogen's Phase 3b Study to Evaluate Extended Interval Dosing (EID) with Natalizumab in Multiple Sclerosis - HTML (w)

2018.12.17 | 13:30 | Permanent Information Releases / General Company News

BIOGEN IDEC INC

Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis - HTML (w)

More documents (2456)

Financial transactions

2018.09.19 | 21:31 | Public offerings / Press Releases during Offer Period

ELI LILLY & CO.

Elanco Announces Pricing of Initial Public Offering - HTML (w)

2016.09.01 | 15:56 | Public offerings / Information note / Note in response

PROCTER & GAMBLE COMPANY

Procter & Gamble Commences P&G Specialty Beauty Brands Exchange Offer - HTML (w)

2016.09.01 | 15:56 | Public offerings / Information note / Note in response

PROCTER & GAMBLE COMPANY

PROCTER & GAMBLE ANNONCE L'OUVERTURE DE L'OFFRE D'ECHANGE CONCERNANT LES MARQUES DE BEAUTE SPECIALISEES P&G - HTML (w)

2016.05.12 | 16:39 | Financial transactions / Prospectuses

ABBVIE INC.

AbbVie Files Form 424B5 - PDF (400Kb)

2015.05.22 | 18:34 | Public offerings / Information note / Note in response

ABBVIE INC.

AbbVie Files an Amended Tender Offer Statement - PDF (192Kb)

More documents (27)